Health Care/Hospital

Always on Alert for Balance Loss with "The Balance Assessment Device," An Outstanding Innovation by Chula Researcher

Chula  Engineering lecturer's innovation "The Balance Assessment Device"—gold medal winner at ITEX 2023 , Malaysia, and recipient of World Invention Intellectual Property Associations' (WIIPA) Special Award (Gold Medal )—checks...

2023-11-15 10:00 1302

2023 World Laureates Association Prize winners awarded in Shanghai

SHANGHAI, Nov. 14, 2023 /PRNewswire/ -- The five winners of the 2023 World Laureates Association Prize (WLA Prize) received their awards for their ground-breaking achievements in computer science or mathematics and life science or medicine onNov. 6 at the opening ceremony of the 6th WLA Forum hel...

2023-11-15 09:54 3596

BioDuro-Sundia Radioisotope Laboratory Technology Upgrades Accelerate Innovation

SHANGHAI, Nov. 15, 2023 /PRNewswire/ -- Radioisotope assays a microanalytical method that uses radionuclides as tracers to label research objects. Compared with conventional biological sample detection techniques, Radioisotope assay has distinct advantages such as high specificity, high sensitivi...

2023-11-15 09:00 1329

EDAN's Focus on Medical Technology Advancement Shines at MEDICA 2023

DUSSELDORF, Germany, Nov. 14, 2023 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its innovative range of new products at MEDICA 2023 inGermany. This grand event, anticipated to draw over 81,000 v...

2023-11-14 22:31 1323

Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT

- Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market SEOUL, South Korea, Nov. 14, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced that it has received U.S....

2023-11-14 22:00 1374

PepsiCo Sets Goals to Further Reduce Sodium and Deliver More Diverse Ingredients in Convenient Foods Portfolio

PURCHASE, N.Y., Nov. 14, 2023 /PRNewswire/ -- Today, PepsiCo, Inc. (NASDAQ: PEP) announced two new ambitious nutrition goals as part of PepsiCo Positive (pep+) – the company's end-to-end strategic transformation – which aim to reduce sodium and purposefully deliver important sources of nutrition ...

2023-11-14 22:00 1362

Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target

GAITHERSBURG, Md., Nov. 14, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2023-11-14 21:30 1154

Geekplus projects win in three categories in the 2023 Supply Chain Excellence Awards

* Geekplus, beside partners Asda Logistics, AMH Material Handling and Dr. Max Romania, has been recognized as the best project in three different ACEA award categories: The Unipart Logistics Digital Transformation Award, The Healthcare & Pharmaceutical Supply Chain Excellence Award, and the Vi...

2023-11-14 21:06 1181

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited  (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore -based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherap...

2023-11-14 20:47 987

Wyeth Becomes the First Multinational Company to Launch an HMO Growing-Up Infant Formula in China

SUZHOU, China, Nov. 14, 2023 /PRNewswire/ -- On November 13th, 2023, Wyeth Nutrition announced the launch of its first illuma HMO Growing-up infant formula added with two human milk oligosaccharides (HMOs) inChina. Designed for babies above 3 years old, this product is manufactured at the company...

2023-11-14 20:14 1377

AXA Introduces "Better She"

First Comprehensive Menopausal Health Management Programme[1] in HK Supporting Women in Hong Kong to Reclaim Their Health and Be On Track for 100% Selves HONG KONG, Nov. 14, 2023 /PRNewswire/ -- AXA Hong Kong and Macau is proud to introduce the"Better She" Programme ("Better She"), the first meno...

2023-11-14 12:12 1525

George Clinical Partners with Medidata to Unlock Operational Efficiency in Clinical Trials

Medidata's Rave Grants Manager will be implemented across 50 multinational studies and multiple therapeutic areas SYDNEY, Nov. 14, 2023 /PRNewswire/ -- Medidata, a Dassault Systèmes company, announced today that George Clinical, a leading global clinical research organization, is leveraging Med...

2023-11-14 10:48 1411

HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO

SYDNEY, Nov. 13, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage Australian biotech, is pleased to announce the appointment ofDamian Clarke-Bruce as Managing Director and CEO, effective13 November 2023. Outgoing CEO Bryce Carmine will remain active in the company, retaining his role as Cha...

2023-11-14 08:27 1056

Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023

Direct evidence that BRII-179-induced functional antibody responses can contribute to increased and sustained HBsAg loss rate New insight in utilizing BRII-179 to enriching patients with intrinsic humoral immune responses for higher HBsAg loss or HBV functional cure rates New data support ...

2023-11-14 06:40 1242

Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023

Direct evidence that BRII-179-induced functional antibody responses can contribute to increased and sustained HBsAg loss rate New insight in utilizing BRII-179 to enriching patients with intrinsic humoral immune responses for higher HBsAg loss or HBV functional cure rates New data support ...

2023-11-14 06:40 1408

Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®

MELBOURNE, Australia, Nov. 14, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a conditional Term Sheet to acquire QSAM Biosciences, Inc. (QSAM) and its lead asset, CycloSam® (Samarium-153-DOTMP). QSAM is a United States (U.S.) based...

2023-11-14 06:33 1223

Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety

PHILADELPHIA, Nov. 14, 2023 /PRNewswire/ -- Rx-360 is pleased to announce that the consortium membership led by key members of the Supplier Quality Working Group have released two new papers this week to help drive best practices in pharmaceutical supply chain integrity and patient safety. The t...

2023-11-14 03:00 1357

SCG Cell Therapy Announces Late-Breaking Clinical Data at AASLD Showing SCG101 Improved Tumor Reponses and Achieved Sustained Antiviral Activates in Patients with Advanced HBV-related Hepatocellular Carcinoma

SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced late-breaking clinical data from its first-in-class autologous hepatitis B virus ...

2023-11-14 02:00 2334

More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds

Global research from the International Diabetes Federation reveals that 72% of people living with diabetes only received their diagnosis because they had at least one of the related complications – such as loss of vision, nerve damage or heart disease. BRUSSELS, Nov. 14, 2023 /PRNewswire/ -- Sev...

2023-11-14 00:36 1444

Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries

Program aims to address key barriers to genomic sequencing in-country SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to p...

2023-11-13 22:15 1462
1 ... 66676869707172 ... 807